Evidence map›Paper›PMID 37568773›Full record

ArticleCancers2023

A Fully Automated Post-Surgical Brain Tumor Segmentation Model for Radiation Treatment Planning and Longitudinal Tracking.

Karthik K Ramesh, Karen M Xu, Anuradha G Trivedi, Vicki Huang, Vahid Khalilzad Sharghi, Lawrence R Kleinberg, Eric A Mellon, Hui-Kuo G Shu, Hyunsuk Shim, Brent D Weinberg

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karthik K RameshDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Karen M XuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Anuradha G TrivediDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-3348-4529
Vicki HuangDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0003-3029-4700
Vahid Khalilzad SharghiSiemens Healthineers, Atlanta, GA 30329, USA.
Lawrence R KleinbergDepartment of Radiation Oncology, Johns Hopkins University, Baltimore, MD 21218, USA.ORCID 0000-0003-2473-2305
Eric A MellonDepartment of Radiation Oncology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 45056, USA.
Hui-Kuo G ShuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hyunsuk ShimDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Brent D WeinbergWinship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-7992-1747

Funding

Improved whole-brain spectroscopic MRI for radiation therapy planningU01CA264039 · NCI · EMORY UNIVERSITY · PI Lee Cooper, Eric Albert Mellon · 2022 to 2026
$3.1M
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patientsR01CA214557 · NCI · EMORY UNIVERSITY · PI SHIM, HYUNSUK, SHU, HUI-KUO · 2017 to 2019
$739k
Automated imaging analysis tools to guide clinical decision making in brain tumor patientsF31CA247564 · NCI · EMORY UNIVERSITY · PI RAMESH, KARTHIK · 2020 to 2024
$235k
NCI NIH HHS F31 CA247564NCI NIH HHS R01 CA214557NCI NIH HHS U01 CA264039NIH HHS F31CA247564NIH HHS R01CA214557NIH HHS U01CA264039
6 · The paper itself

Abstract

Glioblastoma (GBM) has a poor survival rate even with aggressive surgery, concomitant radiation therapy (RT), and adjuvant chemotherapy. Standard-of-care RT involves irradiating a lower dose to the hyperintense lesion in T2-weighted fluid-attenuated inversion recovery MRI (T2w/FLAIR) and a higher dose to the enhancing tumor on contrast-enhanced, T1-weighted MRI (CE-T1w). While there have been several attempts to segment pre-surgical brain tumors, there have been minimal efforts to segment post-surgical tumors, which are complicated by a resection cavity and postoperative blood products, and tools are needed to assist physicians in generating treatment contours and assessing treated patients on follow up. This report is one of the first to train and test multiple deep learning models for the purpose of post-surgical brain tumor segmentation for RT planning and longitudinal tracking. Post-surgical FLAIR and CE-T1w MRIs, as well as their corresponding RT targets (GTV1 and GTV2, respectively) from 225 GBM patients treated with standard RT were trained on multiple deep learning models including: Unet, ResUnet, Swin-Unet, 3D Unet, and Swin-UNETR. These models were tested on an independent dataset of 30 GBM patients with the Dice metric used to evaluate segmentation accuracy. Finally, the best-performing segmentation model was integrated into our longitudinal tracking web application to assign automated structured reporting scores using change in percent cutoffs of lesion volume. The 3D Unet was our best-performing model with mean Dice scores of 0.72 for GTV1 and 0.73 for GTV2 with a standard deviation of 0.17 for both in the test dataset. We have successfully developed a lightweight post-surgical segmentation model for RT planning and longitudinal tracking.

Indexed as

deep learningglioblastomalongitudinal trackingradiation treatmentsegmentation

Identifiers

PMID37568773
PMCPMC10417353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.